Home

Other Sciences

Mathematics

November 9, 2018

November 9, 2018, Rice University

Credit: 123RF.com/Rice University
Mathematical modeling can improve the flu vaccine’s effectiveness, according to experts at Rice University—where one such model has existed for more than 15 years—and its Baker Institute for Public Policy.

Michael Deem, the John W. Cox Professor of Biochemical and Genetic Engineering at Rice; Melia Bonomo, a Ph.D. candidate in physics and astronomy at the university; and Kirstin Matthews, a fellow in science and technology policy in the Center for Health and Biosciences at the Baker Institute, outlined their insights in a new policy brief, “Improving the Effectiveness of the Annual Flu Vaccine.”
Seasonal influenza (flu) causes as many as 49 million illnesses and 79,000 deaths in the United States annually since 2010. To combat its impact, the Centers for Disease Control and Prevention (CDC) recommends all healthy children and adults obtain a flu vaccination every year. In 2017-18, 58 percent of healthy children (6 months to 17 years old) and only 37 percent of adults obtained the vaccine. Approximately 80 percent of pediatric deaths from influenza during that season were children who were unvaccinated.
“To develop a vaccine in time for the beginning of flu season in the fall, scientists must start in early January,” the authors wrote. “The current method that the CDC uses involves scientists vaccinating ferrets with several vaccine candidates. They then extract the antibodies from the ferrets to estimate which vaccine was the most effective against the dominant viruses from the previous flu season. This method has been used for almost 50 years. However, it has been proven to be inconsistent in predicting how well the vaccines would perform in humans, especially with the recent, rapidly mutating A(H3N2) viruses. Additionally, experiments with ferrets are time-consuming and costly.”
By contrast, mathematical models, including a model developed at Rice more than 15 years ago, allow scientists to calculate how well the flu vaccine matches the infecting viruses. The Rice model, called pEpitope, estimates vaccine effectiveness, and it has been shown to work well for flu A(H3N2), A(H1N1) and B vaccines. For the 2018-19 flu season, Rice scientists predict that the vaccine will be between 20 and 40 percent effective against the majority of A(H3N2) viruses.
“Public health researchers are often slow to change,” the authors wrote. “Despite the fact that Rice’s pEpitope model has been around for more than 15 years, it is unclear why the CDC has yet to take advantage of it in developing their seasonal flu vaccine. Adding such a model to the already existing ferret experiments will enhance the current vaccination decision-making process.
“This mathematical modeling technique can rapidly narrow down the viruses that would be good candidates for the vaccine during a particular flu season,” they continued. “It can serve as a check to make sure that the vaccine virus does not mutate during the manufacturing process. The pEpitope model is also low-cost, as it does not require any specialized equipment. Finally, it is extremely quick, taking just a couple of seconds to analyze the potential effectiveness of a vaccine against thousands of infecting viruses in a particular geographic region.”
The authors said the CDC should strengthen its current protocols for choosing vaccine candidates by utilizing all available prediction modeling. “This will improve overall flu vaccine effectiveness rates and potentially coverage rates as well,” they wrote. “Scientists hope that with improved effectiveness, they will also be able to improve vaccine coverage rates, which still trail behind the CDC’s Healthy People 2020 goal of 70 percent. Given the difficulty in producing effective vaccines and the general climate of public mistrust of immunization, this work has the potential to improve vaccine strain selection and education by providing a tool that is accessible to researchers and citizen scientists alike.”

Explore further:
Study predicts 2018 flu vaccine will have 20 percent efficacy

More information:
Improving the Flu Vaccine: www.bakerinstitute.org/researc … roving-flu-vaccines/

Related Stories

Study predicts 2018 flu vaccine will have 20 percent efficacy

April 19, 2018

A Rice University study predicts that this fall’s flu vaccine—a new H3N2 formulation for the first time since 2015—will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the …

AAP updates recommendations for pediatric flu vaccination

September 7, 2018

(HealthDay)—All children and adolescents are advised to undergo annual influenza immunization, ideally with an inactivated influenza vaccine, according to a policy statement published online Sept. 3 in Pediatrics.

How well will the flu vaccine work this winter?

December 13, 2017

The most effective way of preventing seasonal influenza is to be vaccinated each autumn. The reason that people are encouraged to get vaccinated annually is because flu virus can cause severe disease. One of the problems …

Influenza A(H3N2) viruses predominate 2017-2018 season

February 16, 2018

(HealthDay)—Most influenza viruses identified in the 2017 to 2018 season are influenza A, with A(H3N2) viruses predominating, according to research published in the Feb. 16 issue of the U.S. Centers for Disease Control …

H3N2 mutation in last year’s flu vaccine responsible for lowered efficacy

November 6, 2017

The low efficacy of last year’s influenza vaccine can be attributed to a mutation in the H3N2 strain of the virus, a new study reports. Due to the mutation, most people receiving the egg-grown vaccine did not have immunity …

Influenza picking up in U.S., predominantly A(H3N2)

December 8, 2017

(HealthDay)—Influenza activity was low during October 2017 but started increasing in November, with influenza A, predominantly A(H3N2), most commonly identified, according to research published in the Dec. 8 issue of the …

Recommended for you

Study suggests initial success in prestigious institutions key to lifelong artistic achievement

November 9, 2018

An international team of researchers has found that early exposure by certain art institutions is a major factor in lifelong success as an artist. In their paper published in the journal Science, the group describes their …

Reinterpretation of Tulán-52 excavation suggests social complexity among late hunter-gatherers

November 9, 2018

A pair of researchers has found evidence at the Tulán-52 excavation in Chile that suggests the need for a reinterpretation of how the stone complex was used. In their paper published in the journal Antiquity, Lautaro Núñez …

A toast to the proteins in dinosaur bones

November 9, 2018

Burnt toast and dinosaur bones have a common trait, according to a new, Yale-led study. They both contain chemicals that, under the right conditions, transform original proteins into something new. It’s a process that may …

History of early settlement and survival in Andean highlands revealed by ancient genomes

November 8, 2018

A multi-center study of the genetic remains of people who settled thousands of years ago in the Andes Mountains of South America reveals a complex picture of human adaptation from early settlement, to a split about 9,000 …

Tiny footprints, big discovery: Reptile tracks oldest ever found in grand canyon

November 8, 2018

A geology professor at the University of Nevada, Las Vegas, has discovered that a set of 28 footprints left behind by a reptile-like creature 310 million years ago, are the oldest ever to be found in Grand Canyon National …

UK scientists opening up access to science through DIY equipment

November 8, 2018

Scientists at the University of Sussex have developed a piece of hardware to demonstrate how our brains function, as part of a growing range of equipment which uses DIY and 3-D printable models to open up access to science …

0 comments

Original Article can be found by clicking here